Cravatex Key Ratios

BSE: 509472

₹361.80

up-down-arrow ₹-7.95 (-2.15%)

As on 28-Sep-2026IST

Market cap

info icon

₹92 Cr

Revenue (TTM)

info icon

₹160 Cr

P/E Ratio

info icon

10.7

P/B Ratio

info icon

0.8

Div. Yield

info icon

3.7 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -18.45 39.33 -6.51 -26.19 -23.32
EBIT -277.56 43.66 27.42 23.19 12.75
Net Profit -72.58 132.09 189.05 30.71 18.03
EPS -72.64 132.02 189.08 -50.39 18.03
Book Value -- -- 12.22 8.95 44.15
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMMar-26Mar-25
EBIT-Margin info -105.96-4.84-3.16-5.23-1.82
Net Margin info 35.273.414.894.052.63
Return on equity info 23.9358.497.416.024.71
Return on Capital info 26.8117.32--7.926.62
Return on Assets info 19.466.066.004.743.64
Debt to Equity (x) info ----0.000.000.00
ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Cravatex
--
7.92
6.62
6.87
68.80
Peer Median
--
16.93
13.65
20.51
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

7.41

Lower than Peers by 4.32

Profit after tax / Average Net worth * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Cravatex
7.41
6.02
4.71
5.05
276.70
Peer Median
11.73
12.88
11.89
15.90
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

6.00

Lower than Peers by 0.61

Profit after tax / Average Total assets * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Cravatex
6.00
4.74
3.64
3.70
23.51
Peer Median
6.60
6.13
5.53
7.64
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

-3.16

Lower than Peers by 10.51

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Cravatex
-3.16
-5.23
-1.82
-4.70
-9.14
Peer Median
7.34
8.68
8.19
8.54
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

4.89

Lower than Peers by 2.14

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Cravatex
4.89
4.05
2.63
2.21
11.42
Peer Median
7.02
5.87
5.47
6.56
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

--

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Cravatex
--
5.50
3.63
3.31
14.91
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Revenue Growth

-6.51

Lower than Peers by 15.78

Year on year growth in net sales

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Cravatex
-6.51
-13.17
-14.25
-59.77
-15.26
Peer Median
9.26
14.55
29.72
7.05
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

27.42

Higher than Peers by 15.79

Year on year growth in operating profit (EBIT)

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Cravatex
27.42
-149.88
66.84
79.29
-134.21
Peer Median
11.63
23.21
23.89
18.97
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

189.05

Higher than Peers by 173.63

Year on year growth in profit after tax

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Cravatex
189.05
40.77
0.02
-91.81
396.33
Peer Median
15.42
24.69
23.03
10.54
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

189.08

Higher than Peers by 183.19

Year on year growth in earnings per share

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Cravatex
189.08
40.77
0.02
-91.81
396.34
Peer Median
5.89
9.90
4.03
9.38
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

--

--

Year on year growth in book value per share

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Cravatex
--
12.22
7.80
6.89
285.59
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Debt to Equity

--

--

Total debt / Net worth

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Cravatex
--
--
--
--
--
Peer Median
0.01
0.36
0.49
0.32
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

--

--

(Short term borrowings / Net worth)

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Cravatex
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

5.62

Higher than Peers by 3.81

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Cravatex
5.62
5.62
4.22
5.11
2.95
Peer Median
1.81
1.77
1.76
1.79
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

4.68

Higher than Peers by 3.62

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Cravatex
4.68
4.68
3.86
4.64
2.27
Peer Median
1.07
1.15
0.99
1.05
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

31.83

Higher than Peers by 27.82

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Cravatex
31.83
24.60
16.41
16.10
5.22
Peer Median
4.01
3.82
3.00
4.17
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

10.21

Lower than Peers by 16.73

Debtors outstanding / Net Sales * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Cravatex
10.21
10.82
13.79
6.83
5.20
Peer Median
26.94
26.88
32.90
23.57
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

1.12

Higher than Peers by 0.20

Sales / Average Total Assets

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Cravatex
1.12
1.05
1.31
1.55
2.01
Peer Median
0.91
1.06
1.13
1.06
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Cravatex
--
48.74
39.71
36.08
57.77
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Cravatex
--
41.71
23.26
35.77
44.71
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Cravatex
--
49.54
38.15
40.41
30.99
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Cravatex
--
40.91
24.82
31.43
71.48
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Earnings

10.65

Lower than Peers by 27.18

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Cravatex
10.65
11.60
18.34
23.40
1.40
Peer Median
37.83
28.62
36.20
31.36
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

0.76

Lower than Peers by 1.58

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Cravatex
0.76
0.66
0.83
1.14
0.90
Peer Median
2.34
2.51
4.03
3.69
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

3.67

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Cravatex
3.67
4.26
3.65
0.69
0.47
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

1.21

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Cravatex
1.21
0.22
1.58
4.37
-1.51
Peer Median
--
14.09
22.54
19.25
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

92

Lower than Peers by 380

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Cravatex
92
79
89
113
83
Peer Median
471
471
714
610
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...